Open AccessFirst experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†
Author(s) -
Andreas Schaefer,
Eva Harmel,
Moritz Seiffert,
Daniel Reichart,
Florian Deuschl,
Niklas Schofer,
Y. Schneeberger,
Stefan Blankenberg,
Hermann Reichenspurner,
Ulrich Schäefer,
Lenard Conradi
Publication year - 2016
Publication title -
interactive cardiovascular and thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 56
eISSN - 1569-9293
pISSN - 1569-9285
DOI - 10.1093/icvts/ivw446
Subject(s) - medicine , fluoroscopy , cardiology , cardiac catheterization , aortic valvuloplasty , valve replacement , hemodynamics , balloon , aortic valve , stenosis , aortic valve stenosis , surgery
: The aim of this study was to prove technical feasibility and document haemodynamic and clinical outcomes of transcatheter aortic valve implantation (TAVI) with the latest generation repositionable and retrievable Lotus™ transcatheter heart valve (THV) without prior balloon-aortic valvuloplasty (BAV). It has been demonstrated for self-expandable and balloon-expandable THV that implantation without prior BAV is not only feasible and safe but also results in lower fluoroscopy times and amounts of contrast agent while yielding non-inferior haemodynamic and clinical outcome. To date no reports exist for TAVI without BAV for the Lotus™ THV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom